- EPO
is indicated for the treatment of anemia
associated with chronic kidney disease (CKD) including patients in dialysis and patients not on
dialysis.
- It
works by stimulates erythropoiesis by interaction with eryhthropoetin
receptor on progenitor cells in the bone marrow.
- Some
serious side effects that might happen is cardiovascular events such as
thrombosis, stroke and myocardial
infarction. EPO is believed to have pro-thrombotic or platelet-activating
effects which can increase the risk of cardiovascular events.
- Besides that, there is one review on November 2006 in
"Critical Reviews in Oncology Hematology" notes a possible link
between EPO and increased cancer growth. Lung, breast and ovarian cancer were
all found to have receptor sites for EPO on tumor cells, meaning that EPO could
stimulate tumor growth.
- Besides, EPO also can increases blood pressure (BP) directly and notably independently
of its erythropoietic effect and its effect on blood rheology.
- The common side effects that patient might have after taking EPO are
- Dizziness
- Fever
- Swelling
- Nausea
- Pain at the site of
injection
- Adverse drug reactions attributed to the treatment with MIRCERA (available in HKGU) in controlled clinical trials in CKD patients are :
Symptom organ class
|
Frequency
|
Adverse reaction
|
Vascular disorders
|
Common
|
hypertension
|
Injury, poisoning and procedural
complications
|
Uncommon
|
Vascular access thrombosis
|
Nervous system disorders
|
Uncommon
|
Headache
|
Immune system disorders
|
Rare
|
Hypersensitivity
|
Nervous system disorders
|
Rare
|
Hypertensive encephalopathy
|
Skin and subcutaneous tissue disorders
|
Rare
|
Rash (macula-papular, serious)
|
Reference
- http://cjasn.asnjournals.org/content/4/2/470.full
- Product’s Leaflet Mircera (Methoxy polyethylene glycol-epoetin beta)
- http://cardiovascres.oxfordjournals.org/content/59/3/538
- http://www.livestrong.com/article/206029-side-effects-of-procrit-shots/
- http://my.clevelandclinic.org/health/diseases_conditions/hic_Anemia/hic_erythropoietin-stimulating_agents
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.